首页> 外文OA文献 >Approche expérimentale de la physiopathologie des dyskinésies L-Dopa induites dans la maladie de Parkinson : comparaison de la cible classique, le striatum avec l’ensemble du cerveau
【2h】

Approche expérimentale de la physiopathologie des dyskinésies L-Dopa induites dans la maladie de Parkinson : comparaison de la cible classique, le striatum avec l’ensemble du cerveau

机译:帕金森氏病诱发的L型多巴运动障碍的病理生理学实验方法:经典靶标,纹状体与全脑的比较

摘要

The gold standard treatment for Parkinson’s disease (PD) remains the dopamine precursor L- 3,4-dihydroxyphenylalanine (L-Dopa). Long-term L-Dopa treatment systematically leads to abnormal involuntary movements (AIMs) called L-Dopa-induced dyskinesia (LID). These manifestations first led to investigate the neuronal dysfunctions in the motor regions of thebasal ganglia and unravelled an overexpression of ΔFosB, ARC, Zif268 and FRA2 immediate-early genes (IEG) in the dopamine-depleted striatum of dyskinetic rats. However, other several dopaminoceptive structures, likely affected by the exogenously produced dopamine, have been neglected although they might play a key role in mediating LID. Hence, we assessed the expression of ΔFosB, ARC, FRA2 and Zif268 IEGs in the whole brain of dyskinetic rats compared to non-dyskinetic ones. Such approach shed light notably upon 9 structures located outside of the basal ganglia displaying an IEG overexpression. Among them, the dorsolateral bed nucleus of the stria terminalis (dlBST) and the lateralhabenula (LHb) displayed a significant correlation between ΔFosB expression and LID severity. We therefore postulated that these structures might play a role in LID manifestation. Therefore, to assess dlBST and LHb causal roles upon LID severity, we inhibited the electrical activity of FosB/ΔFosB-expressing neurons using the selective Daun02/β- galactosidase inactivation method that we previously validated in a well known structure involve in LID: the striatum. Interestingly, the inactivation of dlBST and LHb ΔfosBexpressing neurons alleviated LID severity and increased the beneficial effect of L-Dopa in dyskinetic rats. Remarkably, BST involvement in LID was confirmed in the gold standard model of LID, the dyskinetic MPTP-lesioned macaque. Altogether, our results highlight for the first time the functional involvement of 2 structures.
机译:帕金森氏病(PD)的金标准疗法仍然是多巴胺前体L-3,4-二羟基苯丙氨酸(L-Dopa)。长期的L-Dopa治疗会系统地导致异常的非自愿运动(AIM),称为L-Dopa诱发的运动障碍(LID)。这些表现首先导致调查了基底神经节运动区的神经元功能障碍,并揭示了运动障碍大鼠多巴胺耗尽的纹状体中ΔFosB,ARC,Zif268和FRA2即早基因(IEG)的过表达。然而,尽管它们可能在介导LID中起关键作用,但可能受到外源产生的多巴胺影响的其他几种多巴胺受体结构却被忽略了。因此,我们评估了运动障碍大鼠与非运动障碍大鼠的大脑中ΔFosB,ARC,FRA2和Zif268 IEG的表达。这种方法显着地揭示了位于基底神经节外侧的9个显示IEG过表达的结构。其中,末端纹状体的背外侧床核(dlBST)和侧ben(LHb)在ΔFosB表达与LID严重程度之间显示出显着的相关性。因此,我们假设这些结构可能在LID表现中起作用。因此,为评估dlBST和LHb在LID严重性上的因果作用,我们使用选择性的Daun02 /β-半乳糖苷酶失活方法抑制了FosB /ΔFosB表达的神经元的电活动,该方法先前已在LID涉及的著名结构中验证: 。有趣的是,dlBST和表达LHbΔfosB的神经元的失活减轻了LID的严重性,并增加了L-Dopa在运动障碍大鼠中的有益作用。值得注意的是,在LID的金标准模型中,证实了BST参与了LID,这是MPTP损伤的运动障碍猕猴。总之,我们的结果首次突出了2个结构的功能参与。

著录项

  • 作者

    Bastide Matthieu;

  • 作者单位
  • 年度 2014
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号